Moderna (NASDAQ:MRNA) stock jumped 10% after the biotechnology company agreed to pay Genevant, a subsidiary of Roivant Sciences (NASDAQ:ROIV), and Arbutus $950 million to settle litigation related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results